National Cancer Intelligence Network
The National Cancer Intelligence Network (NCIN) is a UK-wide initiative, working to drive improvements in standards of cancer care and clinical outcomes by improving and using the information collected about cancer patients for analysis, publication and research.
Macmillan Cancer Support and the National Cancer Intelligence Network are working in partnership to:
use data and information to push the boundaries of understanding of the whole cancer population, now and in the future, of the impact and costs of cancer and its treatment on patients, the wider community and the NHS,
work to enable wider health and social care services to extend the usage of this information to improve the care, experience and outcomes for patients by designing, testing and implementing better models of delivery.
NCIN - Cancer Outcomes Conference - 9 - 10 June 2014
By combining your expertise with ours, together we can do more for people affected by cancer.
The Cancer Outcomes Conference 2014 will explore the ‘power of information’ both locally and nationally, and examine how UK-wide cancer registration data and other health related datasets are being exploited to reduce cancer incidence, mortality and morbidity.
It is happening at the Hilton Birmingham Metropole Hotel from the 9 - 10 June 2014, and aims to enable commissioners to provide the best care and give patients greater power, protection and informed choice.
We'll be showcasing some of our most recent key outputs on the stand and presenting new findings across the conference over the two days which support our exciting Cancer Population Evidence Programme.
To learn more about the conference, please visit the NCIN - Cancer Outcomes Conference web page.
The Macmillan-NCIN Work Plan
To help achieve Macmillan's ambition to reach and improve the lives of everyone living with cancer and inspire millions of others to do the same, we are working in partnership with the NCIN and have developed a Macmillan-NCIN work plan. The objectives of the work plan are to:
provide high quality information on health and its determinants to decision makers who can make changes to improve the lives of the cancer population
describe quantitatively the disease burden of cancer across the whole of the cancer pathway and to develop a strategic approach that will pave the way for large scale analysis across cancer types.
identify key and develop new routine ‘cancer population statistics’.
understand the needs of the cancer population, the health and social impacts of cancer (including cancer recurrence and metastatic disease) and the consequences of its treatment.
understand the ‘cost of cancer’, understanding the cost of providing pathways and model the cost of optimal pathways of care.
understand the linkages between clinical outcomes, patient experience and PROMs (patient reported outcome measures).
scope data requirements for social care and identify potential sources for the development of these datasets (including the extent of provision and cost of providing social care).
continue to develop relationships across UK nations and to access data and influence the range and depth of data collection and quality of recording, understanding what data is available and what the gaps are.
For more information about the partnership, work plan priorities and future work download the summary.